prednisolone has been researched along with Hyphema in 12 studies
Prednisolone: A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states.
prednisolone : A glucocorticoid that is prednisone in which the oxo group at position 11 has been reduced to the corresponding beta-hydroxy group. It is a drug metabolite of prednisone.
Hyphema: Bleeding in the anterior chamber of the eye.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To compare the efficacy of systemic prednisolone and topical tranexamic acid (TA) on the rate of rebleeding in patients with macroscopic traumatic hyphema (MTH)." | 9.51 | Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial. ( Abbaspour, M; Abrishami, M; Bakhtiari, E; Derakhshan, A; Esmaeili, S; Firoozi, J; Zia, MJ, 2022) |
| "In a population with a high rate of secondary bleeding, TA is more effective than oral prednisolone or no oral treatment in preventing rebleeding among patients with traumatic hyphema." | 9.09 | Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. ( Jahadi, HR; Rahmani, B, 1999) |
| "To compare the efficacy of systemic prednisolone and topical tranexamic acid (TA) on the rate of rebleeding in patients with macroscopic traumatic hyphema (MTH)." | 5.51 | Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial. ( Abbaspour, M; Abrishami, M; Bakhtiari, E; Derakhshan, A; Esmaeili, S; Firoozi, J; Zia, MJ, 2022) |
| "In a population with a high rate of secondary bleeding, TA is more effective than oral prednisolone or no oral treatment in preventing rebleeding among patients with traumatic hyphema." | 5.09 | Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial. ( Jahadi, HR; Rahmani, B, 1999) |
| " Secondary hemorrhage had no statistical association with age, gender, oral prednisolone, size of hyphema, and retinal damage." | 5.09 | An analysis of risk for secondary hemorrhage in traumatic hyphema. ( Jahadi, HR; Rahmani, B; Rajaeefard, A, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 2 (16.67) | 18.2507 |
| 2000's | 3 (25.00) | 29.6817 |
| 2010's | 3 (25.00) | 24.3611 |
| 2020's | 1 (8.33) | 2.80 |
| Authors | Studies |
|---|---|
| Derakhshan, A | 1 |
| Firoozi, J | 1 |
| Esmaeili, S | 1 |
| Bakhtiari, E | 1 |
| Abbaspour, M | 1 |
| Abrishami, M | 1 |
| Zia, MJ | 1 |
| Manjandavida, FP | 1 |
| Arepalli, S | 1 |
| Tarlan, B | 1 |
| Shields, CL | 1 |
| Ooi, KG | 1 |
| Gupta, R | 1 |
| Wang, SB | 1 |
| Dance, S | 1 |
| Borovik, A | 1 |
| Francis, IC | 1 |
| Sorrell, MS | 1 |
| Taylor, KH | 1 |
| Fish, RE | 1 |
| Schmitt, AJ | 1 |
| Feilmeier, MR | 1 |
| Piccoli, FV | 1 |
| Ide, T | 1 |
| Yoo, SH | 1 |
| Misra, A | 1 |
| Watts, P | 1 |
| MARTINEZ-ROIG, HE | 1 |
| OJERS, GW | 1 |
| Bruner, WE | 1 |
| Stark, WJ | 1 |
| Green, WR | 1 |
| Rahmani, B | 2 |
| Jahadi, HR | 2 |
| Rajaeefard, A | 1 |
| Romano, PE | 1 |
| Butterworth, SJ | 1 |
3 trials available for prednisolone and Hyphema
| Article | Year |
|---|---|
Systemic prednisolone versus topical tranexamic acid for prevention of rebleeding in patients with traumatic hyphema: A randomized clinical trial.
Topics: Antifibrinolytic Agents; Eye Injuries; Humans; Hyphema; Intraocular Pressure; Prednisolone; Tranexam | 2022 |
Comparison of tranexamic acid and prednisolone in the treatment of traumatic hyphema. A randomized clinical trial.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifibrinolytic Agents; Child; Child, Preschool; Eye | 1999 |
An analysis of risk for secondary hemorrhage in traumatic hyphema.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifibrinolytic Agents; Child; Child, Preschool; Eye | 1999 |
9 other studies available for prednisolone and Hyphema
| Article | Year |
|---|---|
Optical coherence tomography characteristics of epi-iridic membrane in a child with recurrent hyphema and presumed juvenile xanthogranuloma.
Topics: Administration, Topical; Basement Membrane; Female; Fluorescein Angiography; Glucocorticoids; Humans | 2014 |
Spontaneous hyphaema secondary to bleeding from an iris vascular tuft in a patient with a supratherapeutic International normalised ratio: case report.
Topics: Aged, 80 and over; Anticoagulants; Antihypertensive Agents; Atropine; Eye Hemorrhage; Female; Glucoc | 2015 |
Secondary acute anterior uveitis with hyphema in a purpose-bred kitten.
Topics: Administration, Topical; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; | 2008 |
Interface blood after descemet stripping automated endothelial keratoplasty.
Topics: Administration, Topical; Aged, 80 and over; Aza Compounds; Blood Loss, Surgical; Descemet Stripping | 2011 |
Neonatal hyphema in precipitous delivery with dinoprostone.
Topics: Cyclopentolate; Delivery, Obstetric; Dinoprostone; Drug Administration Schedule; Drug Therapy, Combi | 2003 |
The effect of prednisolone upon the absorption of hyphema in rabbit eyes.
Topics: Animals; Eye Hemorrhage; Hyphema; Prednisolone; Rabbits | 1959 |
Presumed juvenile xanthogranuloma of the iris and ciliary body in an adult.
Topics: Acetates; Adult; Ciliary Body; Female; Granuloma; Humans; Hyphema; Iris Diseases; Prednisolone; Pred | 1982 |
Systemic prednisolone prevents rebleeding in traumatic hyphema.
Topics: Administration, Oral; Eye Injuries; Glucocorticoids; Humans; Hyphema; Prednisolone; Recurrence | 2000 |
Resolution of lymphosarcoma associated blindness in a dog following chemotherapy.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Blindness; Cyclophosphamide; Dog Diseases; | 1989 |